Establishment of a leukemia cell line with i(12p) from a patient with a mediastinal germ cell tumor and acute lymphoblastic leukemia. 1994

P A Downie, and N J Vogelzang, and R L Moldwin, and M M Le Beau, and J Anastasi, and R J Allen, and S E Myers, and R A Larson, and S D Smith
Department of Pediatrics, University of Chicago, Illinois 60637-1470.

We report the establishment of a leukemia cell line (UoC-B10) from a patient who developed leukemia several months after the diagnosis of a mediastinal yolk sac tumor. The patient's yolk sac tumor responded to combination chemotherapy, and a mature teratoma with focal areas of hematopoiesis was subsequently resected. However, 5 months after the initial diagnosis, the patient developed an acute lymphoblastic leukemia with a precursor B-cell phenotype. Cytogenetic analysis showed an i(12p) abnormality in the patient's leukemia cells and in the UoC-B10 cell line. The i(12p) was also identified retrospectively in the mediastinal tumor cells by fluorescent in situ hybridization analysis. The UoC-B10 cell line, which has been growing continuously for > 24 months in culture, was Epstein-Barr virus negative and was generally concordant with the patient's leukemia cells by analysis of immunophenotype, karyotype, and genotype. The UoC-B10 cell line possesses receptors for granulocyte-colony-stimulating factor, a cytokine which the patient received as part of his treatment protocol. This cell line may be useful in studying the relationship between i(12p) and hematological differentiation of human mediastinal germ cell tumors.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008297 Male Males
D008479 Mediastinal Neoplasms Tumors or cancer of the MEDIASTINUM. Cancer of Mediastinum,Mediastinal Cancer,Cancer of the Mediastinum,Mediastinum Cancer,Mediastinum Neoplasms,Neoplasms, Mediastinal,Cancer, Mediastinal,Cancer, Mediastinum,Cancers, Mediastinal,Cancers, Mediastinum,Mediastinal Cancers,Mediastinal Neoplasm,Mediastinum Cancers,Mediastinum Neoplasm,Neoplasm, Mediastinal,Neoplasm, Mediastinum,Neoplasms, Mediastinum
D002881 Chromosomes, Human, Pair 12 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 12
D002882 Chromosomes, Human, Pair 13 A specific pair of GROUP D CHROMOSOMES of the human chromosome classification. Chromosome 13
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014178 Translocation, Genetic A type of chromosome aberration characterized by CHROMOSOME BREAKAGE and transfer of the broken-off portion to another location, often to a different chromosome. Chromosomal Translocation,Translocation, Chromosomal,Chromosomal Translocations,Genetic Translocation,Genetic Translocations,Translocations, Chromosomal,Translocations, Genetic
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers

Related Publications

P A Downie, and N J Vogelzang, and R L Moldwin, and M M Le Beau, and J Anastasi, and R J Allen, and S E Myers, and R A Larson, and S D Smith
February 1984, Cancer,
P A Downie, and N J Vogelzang, and R L Moldwin, and M M Le Beau, and J Anastasi, and R J Allen, and S E Myers, and R A Larson, and S D Smith
January 1985, Leukemia research,
P A Downie, and N J Vogelzang, and R L Moldwin, and M M Le Beau, and J Anastasi, and R J Allen, and S E Myers, and R A Larson, and S D Smith
October 1989, Cancer genetics and cytogenetics,
P A Downie, and N J Vogelzang, and R L Moldwin, and M M Le Beau, and J Anastasi, and R J Allen, and S E Myers, and R A Larson, and S D Smith
August 2011, Journal of Korean medical science,
P A Downie, and N J Vogelzang, and R L Moldwin, and M M Le Beau, and J Anastasi, and R J Allen, and S E Myers, and R A Larson, and S D Smith
September 1989, Annals of internal medicine,
P A Downie, and N J Vogelzang, and R L Moldwin, and M M Le Beau, and J Anastasi, and R J Allen, and S E Myers, and R A Larson, and S D Smith
September 1994, British journal of haematology,
P A Downie, and N J Vogelzang, and R L Moldwin, and M M Le Beau, and J Anastasi, and R J Allen, and S E Myers, and R A Larson, and S D Smith
October 1994, Cancer genetics and cytogenetics,
P A Downie, and N J Vogelzang, and R L Moldwin, and M M Le Beau, and J Anastasi, and R J Allen, and S E Myers, and R A Larson, and S D Smith
September 2020, Pediatric investigation,
P A Downie, and N J Vogelzang, and R L Moldwin, and M M Le Beau, and J Anastasi, and R J Allen, and S E Myers, and R A Larson, and S D Smith
January 2003, Cancer genetics and cytogenetics,
P A Downie, and N J Vogelzang, and R L Moldwin, and M M Le Beau, and J Anastasi, and R J Allen, and S E Myers, and R A Larson, and S D Smith
September 2017, Annals of hematology,
Copied contents to your clipboard!